Our results indicate that the COVID-19 pandemic has affected the incidence of mental disorders differently. The incidence rates of OCD in specialist care and eating disorders in both primary- and specialist health care increased during the pandemic. The increase was only apparent among women and most pronounced in the two youngest age groups. On the other hand, in some age groups, the incidence rates of primary care-recorded depression and phobia/OCD, and specialist care-recorded phobic anxiety disorders decreased during the pandemic compared to the pre-pandemic years. There were no differences in the primary care-recorded incidence rates of anxiety disorder and PTSD and in the specialist care-recorded incidence rates of depression, other anxiety disorders, and adjustment disorders during the pandemic compared to the pre-pandemic years. The pandemic affected incidence rates of some disorders and in specific age groups, while most incidence rates followed the underlying trend from before the pandemic.
We found that primary care-recorded incidence rates of depression among some age groups were lower than predicted. This decrease was not found in specialist health care. The result is surprising, as systematic reviews and meta-analyses have found a higher prevalence of self-reported depression in the general population during the pandemic (11, 12, 13). However, the reduction in incidence rates are in line with both Carr et al. (8) and Kazlauskas et al. (7). Our finding extends previous results as we also found a lower incidence rate of depression in primary care during the second pandemic year (2021).
Further, among some age groups, we found decreased incidence rates of phobia/OCD in KUHR and phobic anxiety disorders in NPR during both pandemic years but an increase in the incidence rate of specialist care-recorded OCD in 2021. A decline in the incidence rates of phobia/OCD in primary health care and phobic anxiety disorders in specialist health care is in contrast to the prevalence literature using survey data, as some studies found elevated symptoms of phobic anxiety during quarantine (14) and lockdown (15). However, increased incidence rates of OCD in specialist care align with systematic reviews that have found an increased prevalence of OCD symptoms and the emergence of new symptoms (16, 17, 18).
There might be several explanations for the finding of decreased incidence rates of depression, phobia/OCD, and phobic anxiety disorders during the pandemic. Firstly, the social distancing measures during the pandemic might have reduced some individuals' mental distress (7, 8). People were encouraged, and in some periods forced, to have home-office and home-schooling. Most social gatherings were canceled or reduced to a limited number of participants. Consequently, some people might have avoided situations that could trigger symptoms of mental disorders. This could have reduced the number of people receiving their first-time diagnosis of a mental disorder. Secondly, access to mental health care and GPs in Norway was reduced during periods with strict social distancing measures (19, 20). For instance, people with newly arisen respiratory tract symptoms and those suspected infected with or exposed to the SARS-CoV-2 virus were not allowed to have a face-to-face consultation with their GP or psychologist (19, 20, 21, 22). This might have discouraged some individuals from seeking help. Thirdly, some individuals might have feared being infected at the GPs office or mental health services and stayed home. Since the incidence rates of depression, phobia/OCD, and phobic anxiety disorders have been either stable or had an increasing trend before the pandemic, this might indicate that some people needing mental healthcare did not seek help during the pandemic. If so, this is alarming as untreated mental disorders have been associated with a higher risk of suicide ideation, financial problems, family problems, and discontinuation of work and higher education (23). Future studies should investigate incidence rates across a longer time period after the pandemic to see whether the rates will rebound in the coming years.
Lastly, we found that the incidence rates of primary- and specialist care-recorded eating disorders increased considerably during the pandemic among women. The increase was apparent across all age groups but was most prominent among the youngest age group in 2021. In primary- and specialist health care, the observed incidence rate among 18-24-year-olds was more than 140% higher than predicted. Several countries have reported an alarming increase in the prevalence of eating disorders, especially among young people (24). Our result aligns with Taquet et al. (6), who found increased incidence rates among children and young adults (0–30 years) in 2020. However, they found the largest increase among girls aged 10–14 and 15–19. Increased use of primary- and specialist care for eating disorders during the pandemic have previously been documented among Norwegian children and adolescents (25). Our finding extends previous results, as we found an increase also among adults and during the second pandemic year (2021).
The findings of increased incidence rates of OCD and eating disorders during the pandemic might be explained in several ways. Regarding OCD, there was much focus on disinfection, cleaning, and personal hygiene to help prevent the spread of the virus. There was also much uncertainty regarding how dangerous and contagious the virus was, which resulted in a massive fear of getting infected and infecting others. This might have triggered OCD symptoms, especially for those with contamination symptoms, and led to more people being diagnosed with OCD for the first time (18). There has also been a somewhat increasing trend in the incidence rates of OCD among women in Norway during the study period, which could partly explain the result. Regarding eating disorders, many factors could contribute to the increased incidence rates among women during the pandemic. Firstly, everyone experienced disruptions in their daily routines, such as periods with closed gyms and other indoor activities, which could increase concerns regarding weight and appearance (26). In addition, social media, either in the form of harmful eating/appearance-related content or stressful and traumatic news articles related to the pandemic, could also increase symptoms (26). In general, the COVID-19 pandemic may have acted as a global stressor that triggered the development of OCD and eating disorders among vulnerable individuals.
This study has several strengths. Firstly, we used nationwide data on incidence rates from both primary- and specialist care, thus covering Norway's entire public healthcare system. Secondly, our data captured all patient encounters between 2006/2008–2021 from the entire population, thus making selection bias unlikely. Thirdly, with access to incidence rates from both 2020 and 2021, we added to and extended previous research, which only investigated incidence rates during 2020, the initial stages of the pandemic.
Our study also has some limitations. Firstly, we investigated incidence rates in the two health registries separately. Consequently, an individual could have received a first diagnosis of depression in specialist health care in 2016 but have been registered with a first diagnosis of depression in primary care in 2015. Secondly, subject-level data are available from 2006 in KUHR and from 2008 in NPR. Data during the first years will not only capture true incident cases, but also prevalent cases, as individuals might have been in contact with primary- and specialist care before the inception of the registries. Therefore, we investigated incidence rates between 2015–2021. However, this resulted in a short reference period before the pandemic outbreak (5 years), reducing the prediction models' statistical power. Lastly, in ICPC-2, phobia and OCD are merged in the same diagnostic code (P79), which makes it impossible to interpret whether phobia, OCD, or both disorders declined in primary care. We found opposite trends for phobic anxiety disorders and OCD in specialist health care using ICD-10.